These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22052253)

  • 1. Enhanced antitumor activity of epirubicin combined with cerulenin in osteosarcoma.
    Liu ZL; Wang G; Shu Y; Zou PA; Zhou Y; Yin QS
    Mol Med Rep; 2012 Feb; 5(2):326-30. PubMed ID: 22052253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma.
    Yu L; Meng M; Bao Y; Zhang C; Gao B; Sa R; Luo W
    Yonsei Med J; 2019 Sep; 60(9):832-841. PubMed ID: 31433581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.
    Shiragami R; Murata S; Kosugi C; Tezuka T; Yamazaki M; Hirano A; Yoshimura Y; Suzuki M; Shuto K; Koda K
    Int J Oncol; 2013 Aug; 43(2):431-8. PubMed ID: 23754252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid synthase is a novel therapeutic target in multiple myeloma.
    Okawa Y; Hideshima T; Ikeda H; Raje N; Vallet S; Kiziltepe T; Yasui H; Enatsu S; Pozzi S; Breitkreutz I; Cirstea D; Santo L; Richardson P; Anderson KC
    Br J Haematol; 2008 May; 141(5):659-71. PubMed ID: 18410446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects induced by cycloprodigiosin hydrochloride and epirubicin on human breast cancer cells.
    Yamamoto D; Tanaka K; Nakai K; Baden T; Inoue K; Yamamoto C; Takemoto H; Kamato K; Hirata H; Morikawa S; Inubushi T; Hioki K
    Breast Cancer Res Treat; 2002 Mar; 72(1):1-10. PubMed ID: 12000216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase inhibitor cerulenin inhibits topoisomerase I catalytic activity and augments SN-38-induced apoptosis.
    Jeong NY; Lee JS; Yoo KS; Oh S; Choe E; Lee HJ; Park BS; Choi YH; Yoo YH
    Apoptosis; 2013 Feb; 18(2):226-37. PubMed ID: 23108760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
    Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
    Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
    Menendez JA; Colomer R; Lupu R
    Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran.
    Yu L; Cai L; Hu H; Zhang Y
    J Drug Target; 2014 May; 22(4):343-51. PubMed ID: 24405056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation.
    Zhang Y; Hu H; Song L; Cai L; Wei R; Jin W
    Toxicol Lett; 2013 Sep; 222(1):1-9. PubMed ID: 23845851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma.
    Lamoureux F; Baud'huin M; Ory B; Guiho R; Zoubeidi A; Gleave M; Heymann D; Rédini F
    Oncotarget; 2014 Sep; 5(17):7805-19. PubMed ID: 25138053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27.
    Asanuma F; Yamada Y; Kawamura E; Lee K; Kobayashi H; Yamada T; Suzuki T; Kubota T
    Folia Microbiol (Praha); 1998; 43(5):473-4. PubMed ID: 9821299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice.
    Murata S; Yanagisawa K; Fukunaga K; Oda T; Kobayashi A; Sasaki R; Ohkohchi N
    Cancer Sci; 2010 Aug; 101(8):1861-5. PubMed ID: 20491775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
    Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
    Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
    Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
    Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
    BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.